CTC immune escape mediated by PD-L1

被引:37
|
作者
Wang, Xuefei
Sun, Qiang
Liu, Qiaofei
Wang, Changjun
Yao, Ru
Wang, Yimin
机构
[1] Chinese Acad Med Sci, Breast Surg Dept, Beijing, Peoples R China
[2] Peking Union Med Coll, Peking Union Med Coll & Hosp, Beijing, Peoples R China
[3] Shanxi Prov Peoples Hosp, Xian, Shaanxi, Peoples R China
关键词
BREAST-CANCER; CELLS; SUPPRESSION;
D O I
10.1016/j.mehy.2016.05.022
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Breast cancer is the most common malignant tumor in women around the world. Most breast cancer related deaths are from CTC (circulating tumor cells) metastasis. CTC is associated with the breast cancer patients' prognosis. But recently, circulating clusters were found and its metastasis and tumor formation ability is 23-50 times as CTC. However, its mechanism has not been clarified. These days, researchers have successfully completed CTC cluster separation, CTC cell culture, and PD-L1 was found to be related with histological grading of tumor. Meanwhile, the high expression of PD-L1 in CTC surface has also been reported. Since PD-L1 can mediate Treg to play the role of immunosuppression, we propose that CTC with positive PD-L1 is easier to connect PD-L1, immune cells (Treg regulatory T cells, MDSC bone marrow inhibitory cells) and CM cytokines etc. On one hand, Treg cells can protect CTC from being attacked by the immune system through the immunosuppression, on the other hand, they can weaken CTL killing ability and trigger more MDSC. Finally, CTC formed the metastatic lesion. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:138 / 139
页数:2
相关论文
共 50 条
  • [41] Acidosis-mediated increase in IFN-γ-induced PD-L1 expression on cancer cells as an immune escape mechanism in solid tumors
    Philipp Knopf
    Dimitri Stowbur
    Sabrina H. L. Hoffmann
    Natalie Hermann
    Andreas Maurer
    Valentina Bucher
    Marilena Poxleitner
    Bredi Tako
    Dominik Sonanini
    Balaji Krishnamachary
    Sanhita Sinharay
    Birgit Fehrenbacher
    Irene Gonzalez-Menendez
    Felix Reckmann
    David Bomze
    Lukas Flatz
    Daniela Kramer
    Martin Schaller
    Stephan Forchhammer
    Zaver M. Bhujwalla
    Leticia Quintanilla-Martinez
    Klaus Schulze-Osthoff
    Mark D. Pagel
    Marieke F. Fransen
    Martin Röcken
    André F. Martins
    Bernd J. Pichler
    Kamran Ghoreschi
    Manfred Kneilling
    Molecular Cancer, 22
  • [42] The Tumor Microenvironment Mediates the HIF-1α/PD-L1 Pathway to Promote Immune Escape in Colorectal Cancer
    Sun, Jing
    Zhao, Zhengtian
    Lu, Jiaqi
    An, Wen
    Zhang, Yiming
    Li, Wei
    Yang, Li
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (07)
  • [43] Tumor immunotherapy resistance: Revealing the mechanism of PD-1 / PD-L1-mediated tumor immune escape
    Cui, Jia-Wen
    Li, Yao
    Yang, Yang
    Yang, Hai-Kui
    Dong, Jia-Mei
    Xiao, Zhi-Hua
    He, Xin
    Guo, Jia-Hao
    Wang, Rui-Qi
    Dai, Bo
    Zhou, Zhi-Ling
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 171
  • [44] BCLAF1 binds SPOP to stabilize PD-L1 and promotes the development and immune escape of hepatocellular carcinoma
    Yu, Zongdong
    Wu, Xiang
    Zhu, Jie
    Yan, Huan
    Li, Yuxuan
    Zhang, Hui
    Zhong, Yeling
    Lin, Man
    Ye, Ganghui
    Li, Xinming
    Jin, Jiabei
    Li, Kailang
    Wang, Jie
    Zhuang, Hui
    Lin, Ting
    He, Jian
    Lu, Changjiang
    Xu, Zeping
    Zhang, Xie
    Li, Hong
    Jin, Xiaofeng
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2024, 81 (01)
  • [45] BCLAF1 binds SPOP to stabilize PD-L1 and promotes the development and immune escape of hepatocellular carcinoma
    Zongdong Yu
    Xiang Wu
    Jie Zhu
    Huan Yan
    Yuxuan Li
    Hui Zhang
    Yeling Zhong
    Man Lin
    Ganghui Ye
    Xinming Li
    Jiabei Jin
    Kailang Li
    Jie Wang
    Hui Zhuang
    Ting Lin
    Jian He
    Changjiang Lu
    Zeping Xu
    Xie Zhang
    Hong Li
    Xiaofeng Jin
    Cellular and Molecular Life Sciences, 2024, 81
  • [46] Upregulation of PD-L1 by SPP1 mediates macrophage polarization and facilitates immune escape in lung adenocarcinoma
    Zhang, Yan
    Du, Weiwei
    Chen, Zhaoliang
    Xiang, Cheng
    EXPERIMENTAL CELL RESEARCH, 2017, 359 (02) : 449 - 457
  • [47] KRAS mutation-induced upregulation of PD-L1 mediates immune escape in human lung adenocarcinoma
    Nan Chen
    Wenfeng Fang
    Zhong Lin
    Peijian Peng
    Juan Wang
    Jianhua Zhan
    Shaodong Hong
    Jiaxing Huang
    Lin Liu
    Jin Sheng
    Ting Zhou
    Ying Chen
    Hongyu Zhang
    Li Zhang
    Cancer Immunology, Immunotherapy, 2017, 66 : 1175 - 1187
  • [48] KRAS mutation-induced upregulation of PD-L1 mediates immune escape in human lung adenocarcinoma
    Chen, Nan
    Fang, Wenfeng
    Lin, Zhong
    Peng, Peijian
    Wang, Juan
    Zhan, Jianhua
    Hong, Shaodong
    Huang, Jiaxing
    Liu, Lin
    Sheng, Jin
    Zhou, Ting
    Chen, Ying
    Zhang, Hongyu
    Zhang, Li
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2017, 66 (09) : 1175 - 1187
  • [49] BRD7 Inhibited Immune Escape in Nasopharyngeal Carcinoma via Inhibiting PD-L1 Expression
    Guo, Yilin
    Lu, Jiaxue
    Li, Xiaoxu
    Yan, Shiqi
    Zhou, Jieyu
    Tian, Ziying
    Liu, Ying
    Li, Nan
    Zhou, Qing
    Li, Xiayu
    Shi, Lei
    Jiang, Su
    Li, Mengna
    Zhou, Xiao
    Huang, Donghai
    Zeng, Zhaoyang
    Fan, Songqing
    Xiong, Wei
    Zhou, Ming
    Li, Guiyuan
    Zhang, Wenling
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2025, 21 (05): : 1914 - 1931
  • [50] Comparison Between Immune-Mediated Pneumonitis and Pneumonia in Patients Treated with PD-1/PD-L1 Therapy
    Kim, M. Y.
    Kim, C.
    Kim, Y. J.
    Choi, C.
    Kim, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S594 - S595